Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-31.49	22.29	32.53
Graham Fair Price	-10.89	62454.42	70084.10
PEG	-868.40	-0.60	-0.06
Price/Book	4.94	0.31	0.29
Price/Cash Flow	59.28	-15.18	-37.28
Prices/Earnings	37.87	13.44	9.75
Price/Sales	-4.79	0.86	0.91
Price/FCF	59.28	-15.18	-37.28
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	27.09	0.25	0.20
Operating Margin	101.38	0.12	0.06
ROA	-25.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-23.89
ROIC	< 0.005	0.01	66.01
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	-0.02	200.83
Dividends QOQ	2.18	-0.68	-68.58
EBIT QOQ	5.33	1.27	-76.20
EPS QOQ	1.56	-0.22	-85.76
FCF QOQ	-1.15	-1.63	-42.56
Revenue QOQ	-0.01	0.13	820.77
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	89.93	90.93	1.12
Days Sales Outstanding (DSO)	56.07	57.25	2.11
Inventory Turnover	1.00	0.99	-1.11
Debt/Capitalization	0.60	0.60	1.31
Quick Ratio	0.56	0.63	13.10
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	169901.14	173543.74	2.14
Cash	42320.09	46033.32	8.77
Capex	-9100.12	-3563.64	60.84
Free Cash Flow	-1343.85	-3537.55	-163.24
Revenue	55148.30	62088.05	12.58
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.90	1.00	11.20
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	26.41	18.00	-31.85
Naive Interpretation	Member

06 - Financial Health · Bad

Rating